Table 3:

Individuals with large drops in antibody levels

	Moderna	Pfizer	Combined
Subjects with ≥90% drop	15% (4/27)	33%(5/15)	19%(8/42)
Subjects with ≥95% drop	8% (2/27)	13% (2/15)	10% (4/42)
Subjects with ≥ 99% drop	4 % (1/27)	0%(0/15)	2.4%(1/42)